Akari Therapeutics (AKTX) Free Cash Flow (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.18% |
| Dec 31, 2025 | -43.38% |
| Sep 30, 2025 | 34.86% |
| Jun 30, 2025 | -51.44% |
| Mar 31, 2025 | -1.22% |
| Dec 31, 2024 | -42.55% |
| Sep 30, 2024 | 69.55% |
| Jun 30, 2024 | -21.02% |
| Mar 31, 2024 | 8.28% |
| Dec 31, 2023 | -80.03% |
| Sep 30, 2023 | 47.83% |
| Jun 30, 2023 | 3.81% |
| Jun 30, 2022 | -69.79% |
| Mar 31, 2022 | -100.00% |
| Dec 31, 2021 | 200.00% |
| Sep 30, 2021 | -284,494,001.39% |
| Jun 30, 2021 | 34.41% |
| Mar 31, 2021 | -100.00% |
| Dec 31, 2020 | 200.00% |
| Sep 30, 2020 | -264.31% |
| Jun 30, 2020 | 200.00% |
| Mar 31, 2020 | -223,411,793.72% |
| Dec 31, 2019 | 29.45% |
| Sep 30, 2019 | -2.89% |
| Jun 30, 2019 | -2,184.57% |
| Mar 31, 2019 | 104.81% |
| Dec 31, 2018 | 10.69% |
| Sep 30, 2018 | 35.64% |
| Jun 30, 2018 | -88.36% |
| Mar 31, 2018 | 48.81% |
| Dec 31, 2017 | 6.76% |
| Sep 30, 2017 | -97.41% |
| Jun 30, 2017 | 49.06% |
| Mar 31, 2017 | -38.91% |
| Dec 31, 2016 | -31.96% |
| Sep 30, 2016 | 12.08% |
| Jun 30, 2016 | 23.15% |
| Mar 31, 2016 | -9.28% |
| Dec 31, 2015 | -250.76% |
| Sep 30, 2015 | 743.82% |
| Jun 30, 2015 | 64.92% |
| Mar 31, 2015 | -197.69% |
| Dec 31, 2014 | -118.73% |
| Sep 30, 2014 | 253.23% |
| Jun 30, 2014 | -13.67% |